Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tempus AI, Inc. - Class A Common Stock
(NQ:
TEM
)
58.01
-2.96 (-4.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tempus AI, Inc. - Class A Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection
April 29, 2025
From
Tempus AI, Inc.
Via
Business Wire
Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform
April 28, 2025
From
Tempus AI, Inc.
Via
Business Wire
Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio?
April 27, 2025
Top mid-cap stock performers last week: Ascentage Pharma, Ardagh Metal, Bitdeer Tech, Pegasystems, Impinj, Lufax, Tempus AI, Kymera Therapeutics.
Via
Benzinga
Topics
Artificial Intelligence
Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
April 25, 2025
From
Tempus AI, Inc.
Via
Business Wire
Tempus to Report First Quarter 2025 Financial Results on May 6
April 24, 2025
From
Tempus AI, Inc.
Via
Business Wire
Beyond The Numbers: 9 Analysts Discuss Tempus AI Stock
April 24, 2025
Via
Benzinga
Topics
Artificial Intelligence
Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now?
April 23, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Stocks
Tempus AI Stock Is Ripping Higher Wednesday: What's Fueling The Move?
April 23, 2025
Tempus AI Inc (NASDAQ:TEM) shares are surging Wednesday after the company announced a multi-year collaboration with AstraZeneca PLC (NASDAQ:AZN) and Pathos AI.
Via
Benzinga
Topics
Artificial Intelligence
Tempus AI Stock Surges Nearly 16% on Strategic Partnerships and AI-Driven Oncology Breakthroughs
April 23, 2025
April 23, 2025 – Tempus AI, Inc. (NASDAQ: TEM), a leading precision medicine company leveraging artificial intelligence (AI) for diagnostic and therapeutic advancements, saw its Class A Common Stock...
Via
MarketMinute
Topics
Artificial Intelligence
Stocks
World Trade
Why Tempus AI Stock Is Skyrocketing Today
April 23, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday
April 23, 2025
Via
Benzinga
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
April 23, 2025
From
Tempus AI, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
April 18, 2025
Via
Benzinga
Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.
April 18, 2025
From
Tempus AI, Inc.
Via
Business Wire
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
April 16, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:ILMN),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:MDAI) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
3 Hot New IPOs Defying the 2025 Market Slump
April 14, 2025
Tempus AI, ServiceTitan, and CoreWeave are 2025 IPO standouts, defying a down market. Here’s how they’re beating the S&P 500 so far this year.
Via
MarketBeat
Topics
Artificial Intelligence
Initial Public Offering
Stocks
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
April 14, 2025
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Via
Benzinga
Topics
Animal Testing
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
April 16, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Cathie Wood's Thursday Plays: Healthcare AI And Crypto — Ark Scoops Up Tempus AI and Coinbase Stock Amid Trump Tariff Crash
April 10, 2025
Ark Invest made major buys in Tempus AI and Coinbase on Thursday, as markets slid amid economic uncertainty and Trump's new 145% China tariffs.
Via
Benzinga
Topics
Artificial Intelligence
Government
Cathie Wood Loads Up On $18.2 Million Worth Of Nvidia Stock, Adds $5.8 Million Worth Of Amazon Shares To Her Shopping Cart Amid Trump Tariff Upheaval
April 08, 2025
Cathie Wood's Ark Invest made bold moves Tuesday, buying millions worth of Amazon, NVIDIA, Tempus AI, and Coinbase shares across its ETFs.
Via
Benzinga
Topics
Artificial Intelligence
Government
Does Nvidia-Backed CoreWeave's Lackluster IPO Signal the AI Stock Boom Is Officially Over?
April 02, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Initial Public Offering
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
March 29, 2025
From
Tempus AI, Inc.
Via
Business Wire
4 Healthcare Stocks With Massive Gains—and More to Come
March 29, 2025
Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.
Via
MarketBeat
Topics
Artificial Intelligence
Economy
World Trade
Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference
March 26, 2025
From
Tempus AI, Inc.
Via
Business Wire
Intuitive Machines Posts Q4 Results, Joins Tesla, AnaptysBio, Coherent And Other Big Stocks Moving Higher On Monday
March 24, 2025
Via
Benzinga
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs
March 25, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:TDOC),(NASDAQ:TALK),(NASDAQ:BFRG) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Cathie Wood's Big Tuesday Bet: Ark Pours $7.8 Million Into Tempus AI Despite Stock Stumble
March 18, 2025
On Tuesday, March 18, 2025, Ark Invest, led by Cathie Wood, purchased $7.83 million shares of Tempus AI.
Via
Benzinga
Topics
Artificial Intelligence
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs
March 25, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Cathie Wood Hunts For Crypto Bargains Amid Bitcoin Decline, Ark Loads Up On Robinhood And Coinbase
March 13, 2025
On Thursday, Cathie Wood‘s Ark Invest made significant trades, focusing on acquiring shares in Robinhood Markets Inc (NASDAQ:HOOD), Coinbase Global Inc (NASDAQ:COIN), and
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.